Ocular Therapeutix director granted RSUs and options
Hong Seung Suh reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Hong Seung Suh reported acquisition or exercise transactions in this Form 4 filing.
Ocular Therapeutix director Seung Suh Hong received new equity awards as part of board compensation. He was granted 14,000 restricted stock units, each representing one future share of common stock, and 44,000 stock options to buy common shares at $8.74 per share.
The awards vest in full on the first anniversary of the June 10, 2026 grant date, or earlier immediately before the next annual stockholder meeting, as long as he continues serving on the board. After the grant, he directly holds 60,933 common shares and 44,000 options.
Insider Trade Summary
Grant/Award: 58,000 shares
Grant/Award
2 txns
Insider
Hong Seung Suh
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 44,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 14,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 44,000 contracts (Direct);
Common Stock — 60,933 shares (Direct)
Footnotes (2)
- F1. On June 10, 2026, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
- F2. Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
Key Figures
Restricted stock units granted: 14,000 RSUs
Stock options granted: 44,000 options
Option exercise price: $8.74 per share
+3 more
6 metrics
Restricted stock units granted
14,000 RSUs
Grant to director on June 10, 2026
Stock options granted
44,000 options
Director equity award on June 10, 2026
Option exercise price
$8.74 per share
Stock Option (Right to Buy)
Option expiration
June 9, 2036
End of option term
Common shares after grant
60,933 shares
Direct holdings following RSU award
Underlying option shares
44,000 shares
Common stock underlying options
Key Terms
restricted stock units, 2021 Stock Incentive Plan, Stock Option (Right to Buy), vesting, +1 more
5 terms
restricted stock units financial
"the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Stock Incentive Plan financial
"RSUs under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc."
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
vesting financial
"the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price": "8.7400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Ocular Therapeutix (OCUL) director Seung Suh Hong receive?
He received 14,000 restricted stock units and 44,000 stock options. Each RSU equals one future common share, while each option allows purchase of one share at $8.74, subject to vesting conditions.
What are the vesting terms of the new OCUL RSUs and options for Hong?
Both the 14,000 RSUs and 44,000 options vest 100% after one year. Vesting occurs on the first anniversary of the June 10, 2026 grant or immediately before the next annual stockholder meeting, assuming continued board service.
What is the exercise price and expiration date of Hong’s OCUL stock options?
The 44,000 stock options have a fixed exercise price of $8.74 per share. They are scheduled to expire on June 9, 2036, giving a long window to exercise once vested, subject to plan terms.
Are Hong’s new OCUL equity awards tied to a stock incentive plan?
Yes, the 14,000 restricted stock units were granted under Ocular Therapeutix’s 2021 Stock Incentive Plan, as amended. The options follow similar plan-based terms, including vesting conditions linked to continued board service and a defined expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates